Share: Facebook Twitter LinkedIn
Activity Provided By:

Integritas Communications

Evolving Management Strategies for Moderate-to-Severe Atopic Dermatitis: Looking Beyond Barriers to Optimize Therapy

Access Activity

Overview / Abstract:

Atopic dermatitis is a common, chronic inflammatory disease that manifests primarily in the skin, although research has uncovered potentially deleterious effects in other organ systems throughout the body.1,2 The disease-related physical and biopsychosocial burdens of atopic dermatitis can have a substantial effect on patients’ quality of life, particularly in those with moderate-to-severe disease.3,4 A better understanding of atopic dermatitis etiology has supported the development of new approaches to disease characterization and targeted therapies.5,6 As a result, the first biologic therapy is now available to treat patients with moderate-to-severe disease, and several other therapies are in late-stage clinical development.7-10 With novel therapies emerging for patients with difficult-to-treat atopic dermatitis, dermatologists will benefit from updates on the latest clinical trial data and practical recommendations on how to translate those results into daily clinical decision-making. In this Evidence-Based Best Practices™ program, internationally recognized experts will review the latest published evidence with a goal of providing recommendations to enhance overall patient outcomes. The expert faculty panel will discuss the pathophysiologic underpinnings of atopic dermatitis, share best practices related to comprehensive patient evaluations, and relay their own clinical experience in managing patients with moderate-to-severe disease.

Expiration

Nov 29, 2019

Discipline(s)

Nurse Practitioner , Nursing CNE, Occupational Therapy CE, Pharmacy CPE, Physician CME, Physician Assistant CME

Format

Webinar / Webcast / Video

Credits / Hours

1.00

Accreditation

ACCME, CME, CE

Presenters / Authors / Faculty

Marjolein de Bruin-Weller, MD, PhD; Eric L. Simpson, MD, MCR; Andreas Wollenberg, MD, PhD

Sponsors / Supporters / Grant Providers

This activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.

This activity is jointly provided by Global Education Group and Integritas Communications.

Keywords / Search Terms

Integritas Communications CME, CE, Atopic, Derm, Eczema Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map